about
Chlamydia pneumoniae-specific IgE is prevalent in asthma and is associated with disease severitySecondary outcomes of a pilot randomized trial of azithromycin treatment for asthmaSeroprevalence of Mycoplasma pneumoniae and Chlamydia pneumoniae in stable asthma and chronic obstructive pulmonary disease.Infection-mediated asthma: etiology, mechanisms and treatment options, with focus on Chlamydia pneumoniae and macrolides.Isolation of Chlamydia pneumoniae clonal variants by a focus-forming assay.Chlamydia pneumoniae infection enhances cellular proliferation and reduces steroid responsiveness of human peripheral blood mononuclear cells via a tumor necrosis factor-alpha-dependent pathway.Chlamydia pneumoniae infections in asthma: clinical implications.Chlamydophila pneumoniae and Mycoplasma pneumoniae: a role in asthma pathogenesis?Genetic control of susceptibility to pulmonary infection with Chlamydia pneumoniae in the mouse.Neonatal chlamydial infection induces mixed T-cell responses that drive allergic airway disease.Clearance of Chlamydia pneumoniae infection in H-2 class I human leucocyte antigen-A2.1 monochain transgenic mice.Inverse association between Chlamydia pneumoniae respiratory tract infection and initiation of asthma or allergic rhinitis in children.Evidence of chronic Chlamydia pneumoniae infection in patients with Behçet's disease.Chlamydophila pneumoniae enhances secretion of VEGF, TGF-beta and TIMP-1 from human bronchial epithelial cells under Th2 dominant microenvironment.
P2860
Q21090921-761DF797-E1EE-4708-BEB6-DF736BAE1570Q21563468-3422A985-876E-444A-8625-20CD7163F0E2Q33599500-5F0D583C-445A-4A9A-B548-F8722BE6DA3CQ33706917-F4327A2D-A4CE-4471-893A-F7D5F462DAD3Q34132478-40E8861B-C874-45C8-8F42-A89401CA7B2AQ34481798-B3935086-D540-48E6-B494-B49DA5D53135Q35627745-8D3DCE7F-054F-472B-833D-A9F2849E9668Q36165742-97AB7A63-93B1-4ACD-ACE8-8E2448B04091Q37858513-89D7C6EA-9548-49FF-BE2C-8A7E42E9EEB1Q37859521-00D44C43-C6CF-4B11-87E8-F566E0FF8D3DQ37864193-C40A0308-01EF-4B20-8A37-6481A14816B7Q37865216-D0B00EDE-DBA2-4F1C-86F2-0DB5615FA605Q37866634-7499F28B-89EC-4BAE-B717-E2C8250B2F1AQ38487699-8DE1AAC7-B21D-4EFC-8860-1EDE5EF8A0FD
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
Chlamydia pneumoniae and severity of asthma.
@ast
Chlamydia pneumoniae and severity of asthma.
@en
Chlamydia pneumoniae and severity of asthma.
@nl
type
label
Chlamydia pneumoniae and severity of asthma.
@ast
Chlamydia pneumoniae and severity of asthma.
@en
Chlamydia pneumoniae and severity of asthma.
@nl
prefLabel
Chlamydia pneumoniae and severity of asthma.
@ast
Chlamydia pneumoniae and severity of asthma.
@en
Chlamydia pneumoniae and severity of asthma.
@nl
P2093
P2860
P1476
Chlamydia pneumoniae and severity of asthma.
@en
P2093
Eva Wahlström
Hertzen Leena Von
Kari Liippo
Mirja Puolakkainen
Tuula Vasankari
P2860
P356
10.1080/00365540110077155
P577
2002-01-01T00:00:00Z